Summit Trail Advisors, LLC
- SEC CIK
- 0001698478
- Latest filing
- Aug 11, 2026
BCTX holding history
BriaCell Therapeutics Corp. in every 13F filed by Summit Trail Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCTX overviewAll 13F holders of BCTXFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −35,000−100.0% | Sold out | Holders |
| Q3 2024 | 35,000 | $43.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 35,000 | $39.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 35,000 | $100.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 35,000 | $204.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 35,000 | $218.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 35,000 | $224.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 35,000 | $260.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 35,000 | $152.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 35,000 | $197.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 35,000 | $202.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 35,000 | $355.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 35,000 | $290.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 35,000 | $284.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 35,000 | $187.0K | <0.1% | +35,000 | New | Holders |